SCHEMBL4837552

SCHEMBL4837552

COC(=O)Cc1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3ccc(Cl)cc3)c(C(F)(F)F)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 2/20 0.36
PSEN2 P49810 2/20 0.36
APH1B Q8WW43 2/20 0.36
NCSTN Q92542 2/20 0.36
APH1A Q96BI3 2/20 0.36
PSENEN Q9NZ42 2/20 0.36
MMP8 P22894 6/20 0.36
MMP3 P08254 3/20 0.36
PTGER3 P43115 1/20 0.36
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RORC P51449 1/20 0.35
LMNA P02545 2/20 0.35
MMP1 P03956 1/20 0.35
MMP9 P14780 1/20 0.35
MMP13 P45452 1/20 0.35
ADAM17 P78536 1/20 0.35
ATM Q13315 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4843172 0.95 RORC (0.40) MMP8MMP3PTGER3ALDH1A1NPSR1
SCHEMBL4833081 0.94 POLB (0.38) MMP8MMP3PTGER3MAPTALDH1A1
SCHEMBL4842316 0.94 MMP8 (0.41) MMP8MMP3PTGER3MAPTSMN1; SMN2
SCHEMBL4840866 0.93 PSEN1 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4841644 0.91 MMP8 (0.41) MMP8MMP3MAPTALDH1A1NPSR1
SCHEMBL4838439 0.89 MMP8 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4838610 0.88 RORC (0.39) MMP8MMP3PTGER3ALDH1A1NPSR1
SCHEMBL4838229 0.88 PPARD (0.37) MMP8MMP3PTGER3MAPTALDH1A1
SCHEMBL4843184 0.88 MMP8 (0.40) MMP8MMP3PTGER3MAPTALDH1A1
SCHEMBL4840921 0.87 MMP8 (0.42) MMP8MMP3PTGER3RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 PSEN1 100/4885PSEN2 309/4885APH1B 926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.